Skip to main content
MyPeptideMatch logoMyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed February 2026Updated February 2026

Cagrilintide Dosing Protocol: 10 mg Vial — Week-by-Week Titration & Supplies

Higher-volume cagrilintide protocol guide for the 10 mg compounded vial — ideal for patients advancing through mid-to-high dose titration.

Quickstart highlights

Cagrilintide 2.4 mg once weekly combined with semaglutide 2.4 mg (CagriSema) produced 22.7% body weight reduction at 68 weeks in the Phase 3 REDEFINE-1 interim analysis, surpassing both monotherapies.

  • Concentration: 5 mg/mL (10 mg vial + 2 mL bacteriostatic water).
  • At 5 mg/mL: 0.25 mg = 5 units, 0.5 mg = 10 units, 1 mg = 20 units, 2.4 mg = 48 units.
  • REDEFINE-1 Phase 3: CagriSema (cagrilintide 2.4 mg + semaglutide 2.4 mg) produced 22.7% weight loss at 68 weeks.
  • One 10 mg vial provides ~4 maintenance doses at 2.4 mg weekly.
  • Refrigerate; use within 28 days.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-42505Once weekly0.25 mg — 5 units at 5 mg/mL; one 10 mg vial provides 40 starting doses
5-850010Once weekly0.5 mg — 10 units
9-12100020Once weekly1 mg — 20 units
13-16170034Once weekly1.7 mg — 34 units
17+240048Once weekly2.4 mg maintenance — 48 units; 10 mg vial provides ~4 maintenance doses

Reconstitution steps

  1. Draw 2 mL bacteriostatic water; inject slowly down the vial wall.
  2. Swirl gently until lyophilized powder dissolves fully.
  3. Final concentration: 5 mg/mL (10 mg / 2 mL). At 5 mg/mL: 1 unit = 50 µg.
  4. Label with date and 5 mg/mL notation; refrigerate at 2–8 °C.

Supplies needed

12-week plan

  • 1 vial
  • 12 syringes
  • 2 mL bac water
  • 12 alcohol swabs

20-week plan

  • 1 vial
  • 20 syringes
  • 2 mL bac water
  • 20 alcohol swabs

24-week plan

  • 2 vials
  • 24 syringes
  • 4 mL bac water
  • 24 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Provide an efficient 20+ week supply of cagrilintide from the 10 mg vial for patients advancing through the full 2.4 mg titration protocol, particularly when used as part of the CagriSema combination.

Cycle length: 20 weeks on.

Off-cycle: 8 weeks off; monitor weight and metabolic parameters.

Storage & handling

Lyophilized: store below 25 °C. Reconstituted at 5 mg/mL: refrigerate 2–8 °C; use within 28 days. Note: 5 mg/mL concentration — different unit values than the 5 mg vial (2.5 mg/mL).

Injection & tracking tips

  • At 5 mg/mL, units are halved compared to the 5 mg vial (2.5 mg/mL). The 2.4 mg maintenance dose is 48 units (not 96 units).
  • The 10 mg vial provides approximately 4 maintenance doses at 2.4 mg — plan reconstitution every 4 weeks.
  • Store vial upright in the refrigerator door; avoid temperature fluctuations from frequent door opening.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Track weekly body weight at the same time of day (fasted, morning).
  • Record GI symptom severity using a 0–10 scale for the first 16 weeks.
  • Monitor blood glucose weekly if using alongside semaglutide for the CagriSema protocol.
Log your cycle in the calculator →

How this works & references

Cagrilintide 2.4 mg once weekly combined with semaglutide 2.4 mg (CagriSema) produced 22.7% body weight reduction at 68 weeks in the Phase 3 REDEFINE-1 interim analysis, surpassing both monotherapies. Amylin receptor activation in the area postrema and hypothalamic ARC reduces meal size, delays gastric emptying, and suppresses meal-stimulated glucagon independently of GLP-1 receptor pathways.

Sources

Frequently asked questions

How does the 10 mg vial compare to the 5 mg vial for dosing accuracy?
The 10 mg vial at 5 mg/mL uses smaller unit volumes for low doses (5 units for 0.25 mg versus 10 units), requiring more precision on the syringe. A 30-unit or 50-unit syringe is preferable for doses below 0.5 mg with this vial.
How long does a 10 mg vial last at 2.4 mg/week maintenance?
Approximately 4 weeks — 10 mg ÷ 2.4 mg/dose = 4.17 doses. Always use within 28 days of reconstitution, aligning well with the 4-week life of a single vial at this dose.
Is CagriSema more effective than tirzepatide?
Phase 3 interim data suggests comparable or superior efficacy: CagriSema achieved ~22.7% at 68 weeks versus tirzepatide's 20.9% at 72 weeks (SURMOUNT-1). No head-to-head trials exist.
Can I use cagrilintide with tirzepatide instead of semaglutide?
No clinical trial data supports cagrilintide + tirzepatide combination. The CagriSema trials specifically studied semaglutide as the GLP-1 partner. Off-label combinations should only be considered under close medical supervision.
What happens if I miss a weekly cagrilintide dose?
Inject as soon as possible if within 5 days of the scheduled dose; otherwise skip and resume the next week. Do not double-dose. The 7-day half-life means missing one injection produces only modest plasma level decline before the next scheduled dose.

Related protocols

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.